AI-native platforms are reshaping stem cell research, making regenerative medicine faster, cheaper, and more precise.
Using an innovative combination of biochemical experiments and ultra-high-resolution microscopy, a research team at Kiel ...
Deep inside a small, windowless room at the University of California, Berkeley, two microscopes are quietly capturing some of ...
Sana Biotechnology has become the latest cell therapy biotech to shift resources from cancer to autoimmune diseases as part of a strategic refocus that sounds likely to include a side order of layoffs ...
LB2501: Promising Phase 1 Trial of In Vivo CAR-T Data Demonstrate High Response Rates in B-cell Malignancies ...
In early June 2026, Legend Biotech reported early Phase 1 data for LB2501 in relapsed/refractory B-cell non-Hodgkin lymphoma, showing high response rates, durable in vivo CAR-T expansion without ...
Announcement of a podium presentation at a prestigious symposium, showcasing innovative research in cell therapy for type 1 diabetes. Presentation features promising clinical data on UP421, a novel ...
Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner spanning biology and chemistry.
SingleCell Biotechnology, a biotechnology company developing technologies to measure tumor cell behavior at single-cell resolution, today announced the presentation of new data at the American ...
Yeast’s emergence as a model organism reshaped scientific discovery in cell biology, genetics, and more. Yeast is a ...
As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...
A US biotechnology company has tested a gene therapy designed to reverse ageing in humans for the first time. View on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results